Summary & Overview
CPT 3150F: Unspecified Clinical/Procedural Measure
CPT code 3150F is a CPT-designated code with no narrative summary provided in the source input. As a CPT code, it represents a defined clinical or procedural item used in claims, medical records, and quality reporting. Nationally, accurate identification of CPT codes is important for consistent billing, quality measurement, and comparative policy analysis across public and private payers.
Key payers covered in this summary include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what the code represents, the scope of available information, and a clear statement of missing elements. The publication outlines what readers can expect: benchmark-oriented context when available, notes on policy relevance for major insurers, and clinical context where the description provides such detail. Where input data are incomplete—such as service type, site of service, associated modifiers, taxonomies, ICD-10 mappings, and related codes—the text indicates that those fields are not available in the input. This framing helps payers, billing staff, and policy analysts understand the code’s administrative identity and what follow-up data elements are needed for operational or analytical use.
Billing Code Overview
CPT code 3150F is listed without a narrative summary. Based on the code structure and available description, this entry represents a specific clinical or procedural performance measure within the CPT coding framework. The service type and typical site of service are not explicitly described in the input; therefore, the best available guidance is presented below.
-
Service type: Data not available in the input.
-
Typical site of service: Data not available in the input.
This overview provides a concise statement of the code's identity and notes where clinical or site details are unavailable.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult experiencing persistent hoarseness, stridor, or airway obstruction symptoms after head and neck cancer treatment, smoking-related laryngeal disease, or traumatic injury. The patient is evaluated in an otolaryngology clinic and scheduled for a diagnostic and therapeutic airway endoscopy procedure under monitored anesthesia care or general anesthesia. In the operating room or procedure suite, the surgeon performs a direct laryngoscopy and bronchoscopy to visualize the larynx and upper trachea, assess vocal cord mobility, obtain biopsies when indicated, remove obstructing lesions or granulation tissue, and may place or revise tracheostomy or endoscopic stents. Perioperative documentation includes indications, examination findings, procedures performed, anesthesia type, specimens sent, and postoperative airway assessment with follow-up plan and instructions for voice rest or pulmonary precautions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M visit is performed on the same day as the procedure and properly documented. |
57 | Decision for surgery |